Bank of Montreal Portfolio holdings
Bank of Montreal (BMO), established in 1817 as Canada’s first chartered bank and headquartered in Montreal, Quebec (with key operations in Toronto), is a major North American financial institution offering personal and commercial banking, wealth management, and capital markets services. Managing hundreds of billions in assets, BMO serves over 13 million customers, with a strong U.S. presence through BMO Harris Bank, bolstered by its 1984 acquisition of Harris Bank and the 2022 purchase of Bank of the West, expanding its footprint to 32 states. Known for its longevity and stability, BMO has paid dividends since 1829, one of the longest streaks globally, and emphasizes digital innovation and sustainable finance under CEO Darryl White. With a global reach spanning North America, Europe, and Asia, BMO blends its historical roots with a modern focus on customer-centric growth.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$475M |
| 2 |
Blackstone
BX
|
+$315M |
| 3 |
AABA
Altaba Inc
AABA
|
+$298M |
| 4 |
SPDR Gold Trust
GLD
|
+$237M |
| 5 |
Eli Lilly
LLY
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$384M |
| 2 |
Merck
MRK
|
+$284M |
| 3 |
Enterprise Products Partners
EPD
|
+$266M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$261M |
| 5 |
Royal Bank of Canada
RY
|
+$226M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.66% |
| 2 | Miscellaneous | 10.37% |
| 3 | Energy | 9.81% |
| 4 | Technology | 9.71% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
LGMK
3001
DELISTED
LogicMark
LGMK
| $100K | ﹤0.01% |
+6
| New | +$56.3K |
2017 Q4
0 quarters
|
|
3002
Veracyte
VCYT
$3.55B
| $100K | ﹤0.01% |
15,398
| – | – |
2017 Q1
3 quarters
|
|
|
IMMU
3003
DELISTED
Immunomedics Inc
IMMU
| $100K | ﹤0.01% |
6,200
-8,450
| -58% | -$99.7K |
2015 Q4
8 quarters
|
|
|
EMKR
3004
DELISTED
Emcore Corp
EMKR
| $100K | ﹤0.01% |
1,535
| – | – |
2017 Q1
3 quarters
|
|
3005
Arrowhead Research
ARWR
$9.15B
| $99K | ﹤0.01% |
26,706
+13,228
| +98% | +$49.1K |
2014 Q1
15 quarters
|
|
3006
Matsons
MATX
$6.74B
| $99K | ﹤0.01% |
3,305
| – | – |
2013 Q2
18 quarters
|
|
3007
ProShares Short Russell2000
RWM
$156M
| $99K | ﹤0.01% |
+2,350
| New | +$101K |
2017 Q4
0 quarters
|
|
|
LSXMA
3008
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $99K | ﹤0.01% |
3,437
-924
| -21% | -$27.9K |
2016 Q2
6 quarters
|
|
3009
First Trust Preferred Securities and Income ETF
FPE
$6.04B
| $98K | ﹤0.01% |
+4,910
| New | +$98.6K |
2017 Q4
0 quarters
|
|
3010
UFP Technologies
UFPT
$2.28B
| $98K | ﹤0.01% |
3,534
| – | – |
2017 Q3
1 quarter
|
|
3011
UFP Industries
UFPI
$4.25B
| $97K | ﹤0.01% |
2,601
+42
| +2% | +$1.54K |
2013 Q2
18 quarters
|
|
|
AKAO
3012
PUT
DELISTED
Achaogen Inc
AKAO
| $97K | ﹤0.01% |
+9,000
| New | +$113K |
2017 Q4
0 quarters
|
|
|
LPNT
3013
DELISTED
LifePoint Health, Inc.
LPNT
| $97K | ﹤0.01% |
1,941
+254
| +15% | +$12.6K |
2013 Q2
18 quarters
|
|
3014
Invesco S&P Global Water Index ETF
CGW
$1B
| $96K | ﹤0.01% |
2,683
-7,367
| -73% | -$261K |
2014 Q1
15 quarters
|
|
|
TDF
3015
Templeton Dragon Fund
TDF
$241M
| $96K | ﹤0.01% |
4,450
| – | – |
2013 Q2
18 quarters
|
|
3016
Greenlight Captial
GLRE
$480M
| $95K | ﹤0.01% |
4,737
| – | – |
2013 Q2
18 quarters
|
|
|
SFIX
3017
Stitch Fix
SFIX
$347M
| $95K | ﹤0.01% |
+3,680
| New | +$83.9K |
2017 Q4
0 quarters
|
|
|
ASXC
3018
DELISTED
Asensus Surgical, Inc.
ASXC
| $95K | ﹤0.01% |
3,782
+3,769
| +28,992% | +$116K |
2014 Q4
12 quarters
|
|
|
NXGN
3019
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $95K | ﹤0.01% |
7,008
-825
| -11% | -$11.8K |
2013 Q2
18 quarters
|
|
|
GMLP
3020
DELISTED
Golar LNG Partners LP
GMLP
| $95K | ﹤0.01% |
4,164
+69
| +2% | +$1.51K |
2017 Q3
1 quarter
|
|
|
OREX
3021
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $95K | ﹤0.01% |
74,100
+100
| +0.1% | +$163 |
2017 Q1
3 quarters
|
|
|
OREX
3022
PUT
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $95K | ﹤0.01% |
74,000
| – | – |
2017 Q1
3 quarters
|
|
3023
Wolfspeed
WOLF
$1.65B
| $94K | ﹤0.01% |
2,516
+557
| +28% | +$19.2K |
2013 Q2
18 quarters
|
|
|
EPE
3024
DELISTED
EP Energy Corporation
EPE
| $94K | ﹤0.01% |
40,000
-882
| -2% | -$2.11K |
2014 Q3
13 quarters
|
|
|
CIVI
3025
DELISTED
Civitas Solutions, Inc.
CIVI
| $94K | ﹤0.01% |
5,528
| – | – |
2015 Q2
10 quarters
|
|
Similar funds
Bank of Montreal's Q4 2017 Portfolio in Review
As of Q4 2017, Bank of Montreal held 4,524 positions worth $115B, up 5.4% from $109B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Bank of Montreal's Q4 2017 filing shows 340 new, 1,586 increased, 1,488 reduced and 306 closed positions. Its largest new stake was Maxar Technologies Inc. Common Stock: 2,074,218 shares worth $133M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $384M.
By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 27% a quarter earlier, followed by Miscellaneous and Energy.
- Bank of Montreal's largest Q4 2017 buy was Maxar Technologies Inc. Common Stock: 2,074,218 shares worth $133M.
- Bank of Montreal added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $475M increase.
- Bank of Montreal's biggest Q4 2017 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $384M.
- Bank of Montreal fully exited CR Bard Inc. in Q4 2017, selling an estimated $120M.
- Bank of Montreal's ten largest holdings make up 20% of its $115B portfolio in Q4 2017.
- Bank of Montreal opened 340 new positions and closed 306 in Q4 2017.
- Bank of Montreal's portfolio value rose 5.4% quarter-over-quarter to $115B.
Based on Bank of Montreal's 13F filing for Q4 2017, filed 16 Jan 2018.